RhoBAST is a tiny RNA molecule that activates fluorescent dyes, enabling researchers to track RNA molecules in living cells ...

Keshav Bhutada, chief executive officer of Shilpa CDMO, said the company has long been recognized among existing partners for its capabilities with challenging molecules such as high-potency APIs ...

For more than a century, pharmaceutical companies have relied on flat structures called aromatic rings, which can help drugs ...

RNA droplets can concentrate the molecule with no membrane at all, and a single oxygen atom sets how much heat it takes to ...

Carita’s hair products are billed to detoxify, energize and restore.

Taken together, the two studies suggest that naturally occurring bacterial molecules such as gladiolin can act against ...

Harold Bernstein, President of Research and Development and Chief Medical Officer at Maze Therapeutics, Inc. (NASDAQ:MAZE), ...

Opportunities center on genetically targeted therapies, novel CNS pathways and long-acting formulations that improve adherence, with added potential in companion diagnostics, differentiated delivery, ...

EFSA has published a positive safety opinion on S-acetyl glutathione (SAG), a chemically modified version of glutathione ...

Tozorakimab targets IL-33 upstream of TH2 pathways, cutting COPD exacerbations up to 34% in former smokers, Frank Sciurba, MD ...

As of Friday, September 11, BridgeBio Oncology Therapeutics, Inc.’s BBOT share price has dipped by 10.24%, which has ...

Custom search configurations optimize automated synthesis routes for higher success rates, faster planning, and more.